209 completed, 48 terminated, 24 unknown, 8 withdrawn. 156 Phase 2, 84 Phase 1, 38 Phase 3, 22 Not applicable, 2 Early Phase 1.
Follow Multiple Myeloma and Plasma Cell Neoplasm: new trials by email Literature Review of Multiple Myeloma and Plasma Cell Neoplasm trials Research Report on Multiple Myeloma and Plasma Cell Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 68Ga-BCMA PET/CT in Multiple Myeloma 68Ga-BCMA PET/CT - Multiple Myeloma, Multiple Myeloma and Malignant Plasma Cell Neoplasms | Phase 2 / Phase 3 | Recruiting | Peking University First Hospital | 300 | 2025-12-25 | 2026-06-22 |
| Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease anti-thymocyte globulin, sargramostim, therapeutic allogeneic lymphocytes - Chronic Myeloproliferative Disorders, Leukemia | Phase 2 | Completed | UNC Lineberger Comprehensive Cancer Center | 71 | 2011-01-07 | 2017-05-30 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant anti-thymocyte globulin, donor lymphocytes, filgrastim - Leukemia, Lymphoma | Phase 2 | Terminated | Alliance for Clinical Trials in Oncology | 6 | 2010-12-01 | 2017-03-24 |
| Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma bortezomib, hydroxychloroquine - Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 | Completed | Abramson Cancer Center at Penn Medicine | 25 | 2010-09-08 | 2020-02-07 |
| Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation anti-thymocyte globulin, rituximab, sirolimus - Chronic Myeloproliferative Disorders, Graft Versus Host Disease | Phase 2 | Terminated | Barbara Ann Karmanos Cancer Institute | 4 | 2010-08-01 | 2019-03-26 |
| Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer bortezomib, nelfinavir mesylate - Leukemia, Lymphoma | Phase 1 | Completed | Swiss Cancer Institute | 18 | 2010-07-01 | 2019-05-15 |
| Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome Lactobacillus rhamnosus GG - Breast Cancer, Chronic Myeloproliferative Disorders | Not applicable | Terminated | Rutgers, The State University of New Jersey | 30 | 2010-03-01 | 2017-02-03 |
| Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant DNA analysis, polymerase chain reaction, flow cytometry - Cancer Survivor, Chronic Myeloproliferative Disorders | Terminated | Vanderbilt University | 24 | 2010-02-01 | 2014-12-10 | |
| Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma defined green tea catechin extract, gene expression analysis, protein analysis - Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition | Phase 2 | Terminated | Barbara Ann Karmanos Cancer Institute | 8 | 2009-11-01 | 2015-03-27 |
| Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells, autologous hematopoietic stem cell transplantation, peripheral blood stem cell transplantation - Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 | Completed | Barbara Ann Karmanos Cancer Institute | 12 | 2009-10-01 | 2013-09-23 |
| Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation Irradiated haploidentical allogeneic lymphocytes, total-body irradiation - Leukemia, Lymphoma | Phase 1 | Terminated | University of Medicine and Dentistry of New Jersey | 4 | 2009-10-01 | 2013-09-17 |
| Registry of Older Patients With Cancer Chronic Myeloproliferative Disorders, Cognitive/Functional Effects | Recruiting | UNC Lineberger Comprehensive Cancer Center | 3000 | 2009-09-01 | 2026-06-29 | |
| 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer 3'-deoxy-3'-[18F]fluorothymidine - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders | Active not recruiting | Barbara Ann Karmanos Cancer Institute | 2009-09-01 | 2026-08-10 | ||
| Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer biologic sample preservation procedure, cytology specimen collection procedure - Chronic Myeloproliferative Disorders, Leukemia | Recruiting | UNC Lineberger Comprehensive Cancer Center | 15000 | 2009-07-01 | 2025-10-27 | |
| Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma everolimus, panobinostat, laboratory biomarker analysis - Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 | Completed | City of Hope Medical Center | 11 | 2009-07-01 | 2013-02-15 |
| Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma busulfan, cyclophosphamide, autologous hematopoietic stem cell transplantation - Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Completed | Case Comprehensive Cancer Center | 71 | 2009-06-11 | 2020-07-24 |
| Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer methadone hydrochloride, morphine sulfate, oxycodone hydrochloride - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders | Not applicable | Terminated | M.D. Anderson Cancer Center | 1 | 2009-03-01 | 2020-09-24 |
| Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer donor natural killer cell infusion - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders | Phase 1 / Phase 2 | Completed | Asan Medical Center | 47 | 2009-01-01 | 2013-02-20 |
| Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone chemotherapy, dapsone, medical chart review - Chronic Myeloproliferative Disorders, Leukemia | Completed | Vanderbilt University | 41 | 2009-01-01 | 2017-04-17 | |
| Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma dexamethasone, lenalidomide - Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Completed | Mayo Clinic | 39 | 2008-12-03 | 2020-01-18 |
Showing 20 of 295. Sign in to see all of them.
Multiple Myeloma (295) · Neoplasms, Plasma Cell (295) · Lymphoma (169) · Leukemia (167) · Leukemia, Lymphocytic, Chronic, B-Cell (156) · Lymphoma, Follicular (155) · Lymphoma, Large B-Cell, Diffuse (153) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (153) · Lymphoma, Mantle-Cell (151) · Burkitt Lymphoma (145) · Lymphoma, B-Cell, Marginal Zone (145) · Lymphoma, Non-Hodgkin (145) · Lymphoma, Large-Cell, Immunoblastic (144) · Hodgkin Disease (142) · Myelodysplastic Syndromes (137)
Blood Protein Disorders (295) · Cardiovascular Diseases (295) · Hematologic Diseases (295) · Hemic and Lymphatic Diseases (295) · Hemorrhagic Disorders (295) · Hemostatic Disorders (295) · Immune System Diseases (295) · Immunoproliferative Disorders (295) · Neoplasms by Histologic Type (295) · Paraproteinemias (295) · Vascular Diseases (295) · Neoplasms (289) · Lymphoproliferative Disorders (271) · Lymphatic Diseases (175) · Pathological Conditions, Signs and Symptoms (166)
Cyclophosphamide (70) · Peripheral Blood Stem Cell Transplantation (61) · Melphalan (56) · fludarabine phosphate (40) · Busulfan (39) · Filgrastim (39) · Dexamethasone (37) · Antilymphocyte Serum (35) · Radiotherapy (28) · Tacrolimus (28) · Mycophenolic Acid (25) · Cyclosporine (24) · Bortezomib (23) · Methotrexate (20) · Etoposide (18)
Mayo Clinic (24) · Fred Hutchinson Cancer Center (17) · Memorial Sloan Kettering Cancer Center (16) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (15) · Barbara Ann Karmanos Cancer Institute (12) · Case Comprehensive Cancer Center (11) · City of Hope Medical Center (11) · Alliance for Clinical Trials in Oncology (9) · Masonic Cancer Center, University of Minnesota (8) · Northwestern University (8) · University of Maryland, Baltimore (8) · Eastern Cooperative Oncology Group (7) · OHSU Knight Cancer Institute (7) · Roswell Park Cancer Institute (7) · Vanderbilt-Ingram Cancer Center (7)
United States (255) · Canada (10) · United Kingdom (10) · France (6) · Belgium (5) · Germany (3) · Italy (3) · Switzerland (3) · Israel (2) · Netherlands (2) · Poland (2) · Slovakia (2) · South Korea (2) · Turkey (Türkiye) (2) · China (1)
William I. Bensinger, MD (8) · Morie A. Gertz, MD (5) · Shaji K. Kumar, MD (5) · Barry R. Meisenberg, MD (4) · Martha Q. Lacy, MD (4) · Roger Strair, MD, PhD (4) · Thomas E. Witzig, MD (4) · Thomas G. Martin, MD (4) · Angela Dispenzieri, MD (3) · Ann Traynor, MD (3) · Carol A. Huff, MD (3) · Craig B. Reeder, MD (3) · David G. Savage, MD (3) · Didier Blaise, MD (3) · Ephraim J. Fuchs, MD (3)
PMID 10084252, PMID 10414913, PMID 10414914, PMID 10459351, PMID 10482933, PMID 10918404, PMID 12000194, PMID 12171484, PMID 12473574, PMID 14508361, PMID 15107815, PMID 15156165, PMID 15241836, PMID 15570084, PMID 15623591, PMID 15867202, PMID 16224404, PMID 16365178, PMID 16398649, PMID 16419071, PMID 16505427, PMID 16710026, PMID 17233817, PMID 17397698, PMID 18067008, PMID 18166796, PMID 18327587, PMID 18645482, PMID 19170225, PMID 19179301, PMID 19181644, PMID 19188182, PMID 19225538, PMID 19226361, PMID 19243818, PMID 19373653, PMID 19880501, PMID 20124511, PMID 20413666, PMID 20496177, PMID 20864577, PMID 21030558, PMID 21403127, PMID 21479990, PMID 21630308, PMID 21690557, PMID 21715313, PMID 21719601, PMID 21824051, PMID 22157574
P30CA015083 (24), P30CA006973 (14), P30CA022453 (12), P30CA033572 (12), P01CA015396 (7), P30CA043703 (7), P30CA068485 (6), P30CA072720 (6), P30CA016086 (4), P30CA008748 (3), P30CA069533 (3), P30CA016058 (2), U10CA021115 (2), U10CA031946 (2), U10CA032102 (2)